Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Moldvay

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Pathology Oncology Research : POR|December 27, 2006
Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx in paraffin-embedded cancer tissuesKatalin Derecskei, Judit Moldvay, Krisztina Bogos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2016
Differences in the Epidemiology of Rare EGFR Mutations in Different PopulationsZoltan Lohinai, Gyula Ostoros, Judit Moldvay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Reply to Rare Versus Artifactual EGFR MutationsZoltan Lohinai, Gyula Ostoros, Judit Moldvay, et al.
Magyar Onkologia|December 18, 2010
[Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer]György Losonczy, Csaba Máthé, Veronika Müller, et al.
Biomarker Research|February 23, 2016
A robust prognostic gene expression signature for early stage lung adenocarcinomaMarcin Krzystanek, Judit Moldvay, David Szüts, et al.
Magyar Onkologia|April 11, 2013
[Analysis of drug therapy of lung cancer in Hungary]Judit Moldvay, György Rokszin, Zsolt Abonyi-Tóth, et al.
Magyar Onkologia|June 10, 2011
[Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy]Judit Moldvay, Judit Pápay, Rita Puskás, et al.
Magyar Onkologia|July 11, 2014
[Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission]Judit Moldvay, Judit Pápay, Ilona Kovalszky, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2007
Distinct claudin expression profile in histologic subtypes of lung cancerJudit Moldvay, Márta Jäckel, Csilla Páska, et al.
Oncotargets and Therapy|May 23, 2015
Lung cancer drug therapy in Hungary - 3-year experienceJudit Moldvay, György Rokszin, Zsolt Abonyi-Tóth, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Pathology Oncology Research : POR|December 27, 2006
Protocol modifications influence the result of EGF receptor immunodetection by EGFR pharmDx in paraffin-embedded cancer tissuesKatalin Derecskei, Judit Moldvay, Krisztina Bogos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2016
Differences in the Epidemiology of Rare EGFR Mutations in Different PopulationsZoltan Lohinai, Gyula Ostoros, Judit Moldvay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Reply to Rare Versus Artifactual EGFR MutationsZoltan Lohinai, Gyula Ostoros, Judit Moldvay, et al.
Magyar Onkologia|December 18, 2010
[Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer]György Losonczy, Csaba Máthé, Veronika Müller, et al.
Biomarker Research|February 23, 2016
A robust prognostic gene expression signature for early stage lung adenocarcinomaMarcin Krzystanek, Judit Moldvay, David Szüts, et al.
Magyar Onkologia|April 11, 2013
[Analysis of drug therapy of lung cancer in Hungary]Judit Moldvay, György Rokszin, Zsolt Abonyi-Tóth, et al.
Magyar Onkologia|June 10, 2011
[Examination of ERCC1 expression in lung cancer patients treated with platinum-based chemotherapy]Judit Moldvay, Judit Pápay, Rita Puskás, et al.
Magyar Onkologia|July 11, 2014
[Gefitinib treatment in lung cancer -- rebiopsy, retreatment, remission]Judit Moldvay, Judit Pápay, Ilona Kovalszky, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2007
Distinct claudin expression profile in histologic subtypes of lung cancerJudit Moldvay, Márta Jäckel, Csilla Páska, et al.
Oncotargets and Therapy|May 23, 2015
Lung cancer drug therapy in Hungary - 3-year experienceJudit Moldvay, György Rokszin, Zsolt Abonyi-Tóth, et al.
Pageof 11